Literature DB >> 7047399

Iron-suppressible production of hydroxamate by Escherichia coli isolates.

S J Stuart, K T Greenwood, R K Luke.   

Abstract

A total of 476 strains of Escherichia coli isolated from humans, pigs, cattle, poultry, potable water, or effluent were examined for iron-suppressible ability to produce hydroxamate. Isolates able to produce such material (Hyd+ isolates) are presumed to be able to carry out hydroxamate-dependent transport of iron. The percentages of Hyd+ isolates found among E. coli isolated from the feces of breast-fed babies (71%), adults (46%), milk-fed calves (32%), or poultry (28%) were significantly greater (P less than 0.01) than the percentages isolated from potable water and effluent (6%) or from the feces of suckling piglets (6%), weaned pigs (6%), or weaned cattle (4%). The percentages of Hyd+ isolates found among E. coli associated with diarrhea in humans (51%), weaned pigs (7%) or calves (25%) were not significantly different (P greater than 0.1) from those found among strains isolated from corresponding nondiarrheic hosts. Many of the E. coli isolated from cases of E. coli bacteremia in humans and poultry were Hyd+ (64% and 83%, respectively). We conclude that ability to carry out hydroxamate-mediated transport of iron is widely distributed among natural isolates of E. coli but that the distribution of Hyd+ E. coli is not random. E. coli isolated from sources where levels of available iron might be expected to be low tend to be Hyd+. It seems that a link may exist between prevalence of Hyd+ E. coli and active host-defense based on restricted availability of iron.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047399      PMCID: PMC551410          DOI: 10.1128/iai.36.3.870-875.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Membrane receptor dependent iron transport in Escherichia coli.

Authors:  K Hantke; V Braun
Journal:  FEBS Lett       Date:  1975-01-01       Impact factor: 4.124

2.  The isolation and bacteriostatic properties of lactoferrin from bovine milk whey.

Authors:  B A Law; B Reiter
Journal:  J Dairy Res       Date:  1977-10       Impact factor: 1.904

Review 3.  Structure and function of transferrins. II. Transferrin and iron metabolism.

Authors:  R H Zschocke; A Bezkorovainy
Journal:  Arzneimittelforschung       Date:  1974-05

4.  The inducible citrate-dependent iron transport system in Escherichia coli K12.

Authors:  G E Frost; H Rosenberg
Journal:  Biochim Biophys Acta       Date:  1973-11-30

5.  The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-I.

Authors:  F Gibson; D I Magrath
Journal:  Biochim Biophys Acta       Date:  1969-11-18

6.  Transferable drug resistance and other transferable agents in strains of Escherichia coli from two human populations.

Authors:  M J Lewis
Journal:  Lancet       Date:  1968-06-29       Impact factor: 79.321

7.  Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1976-02

8.  Iron-binding proteins in milk and resistance to Escherichia coli infection in infants.

Authors:  J J Bullen; H J Rogers; L Leigh
Journal:  Br Med J       Date:  1972-01-08

9.  Iron-chelating hydroxamic acid (schizokinen) active in initiation of cell division in Bacillus megaterium.

Authors:  B R Byers; M V Powell; C E Lankford
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

10.  Enterochelin system of iron transport in Escherichia coli: mutations affecting ferric-enterochelin esterase.

Authors:  L Langman; I G Young; G E Frost; H Rosenberg; F Gibson
Journal:  J Bacteriol       Date:  1972-12       Impact factor: 3.490

View more
  13 in total

1.  Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection.

Authors:  S H Jacobson; M Hammarlind; K J Lidefeldt; E Osterberg; K Tullus; A Brauner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

2.  Aerobactin production of serotyped Escherichia coli from urinary tract infections.

Authors:  I Orskov; C Svanborg Edén; F Orskov
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

3.  Aerobactin genes in clinical isolates of Escherichia coli.

Authors:  A Bindereif; J B Neilands
Journal:  J Bacteriol       Date:  1985-02       Impact factor: 3.490

4.  Absence of siderophore activity in Legionella species grown in iron-deficient media.

Authors:  M W Reeves; L Pine; J B Neilands; A Balows
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

5.  Composite IS1 elements encoding hydroxamate-mediated iron uptake in FIme plasmids from epidemic Salmonella spp.

Authors:  B Colonna; M Nicoletti; P Visca; M Casalino; P Valenti; F Maimone
Journal:  J Bacteriol       Date:  1985-04       Impact factor: 3.490

6.  RNA-DNA hybridization analysis of transcription of the plasmid ColV-K30 aerobactin gene cluster.

Authors:  M Roberts; R W Leavitt; N H Carbonetti; S Ford; R A Cooper; P H Williams
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

7.  Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia.

Authors:  J Z Montgomerie; A Bindereif; J B Neilands; G M Kalmanson; L B Guze
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Passive immunization with antibodies against iron-regulated outer membrane proteins protects turkeys from Escherichia coli septicemia.

Authors:  C A Bolin; A E Jensen
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections.

Authors:  N H Carbonetti; S Boonchai; S H Parry; V Väisänen-Rhen; T K Korhonen; P H Williams
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

10.  Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals.

Authors:  M Achtman; M Heuzenroeder; B Kusecek; H Ochman; D Caugant; R K Selander; V Väisanen-Rhen; T K Korhonen; S Stuart; F Orskov
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.